Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia.

Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia.

OBJECTIVE: Tryptophan degradation and depletion resulting from activation of indoleamine 2,3-dioxygenase is characteristic of inflammatory reactions and may control their intensity. Normal third-trimester pregnancy is characterized by a maternal systemic inflammatory response, which is more intense...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Kudo, Y, Boyd, C, Sargent, I, Redman, C
Format:	Journal article
Sprache:	English
Veröffentlicht:	2003

Ähnliche Einträge

Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation.
von: Kudo, Y, et al.
Veröffentlicht: (2001)

Modulation of indoleamine 2,3-dioxygenase by interferon-gamma in human placental chorionic villi.
von: Kudo, Y, et al.
Veröffentlicht: (2000)

Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta.
von: Kudo, Y, et al.
Veröffentlicht: (2004)

Indoleamine 2,3-dioxygenase-Mediated Tryptophan Catabolism Limits Experimental Abdominal Aortic Aneurysms
von: Baohui Xu, et al.
Veröffentlicht: (2024-01-01)

Contribution of indoleamine 2,3-dioxygenase in preeclampsia
von: Mona F.M El-Karn, et al.
Veröffentlicht: (2016-01-01)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
von: Lieve Brochez, et al.
Veröffentlicht: (2021-12-01)

Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1
von: Wentao Zhang, et al.
Veröffentlicht: (2023-05-01)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
von: V. A. Kozlov, et al.
Veröffentlicht: (2017-07-01)

Influence of tryptophan contained in 1-Methyl-Tryptophan on antimicrobial and immunoregulatory functions of indoleamine 2,3-dioxygenase.
von: Silvia K Schmidt, et al.
Veröffentlicht: (2012-01-01)

The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
von: Knut A. Hestad, et al.
Veröffentlicht: (2017-10-01)

Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis.
von: Criado, G, et al.
Veröffentlicht: (2009)

Indoleamine 2,3-dioxygenase in endometriosis
von: Hui-Li Yang, et al.
Veröffentlicht: (2019-01-01)

Interleukin‐6 promotes skeletal muscle catabolism by activating tryptophan–indoleamine 2,3‐dioxygenase 1–kynurenine pathway during intra‐abdominal sepsis
von: Tingbin Xie, et al.
Veröffentlicht: (2023-04-01)

The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression
von: Dustin T. Nguyen, et al.
Veröffentlicht: (2023-01-01)

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
von: Peng X, et al.
Veröffentlicht: (2022-08-01)

Associations of microbial and indoleamine-2,3-dioxygenase-derived tryptophan metabolites with immune activation in healthy adults
von: Niknaz Riazati, et al.
Veröffentlicht: (2022-09-01)

Indoleamine 2, 3-Dioxygenase-Mediated Tryptophan Catabolism: A Leading Star or Supporting Act in the Tuberculosis and HIV Pas-de-Deux?
von: Clement Gascua Adu-Gyamfi, et al.
Veröffentlicht: (2019-10-01)

Rational design of indoleamine 2,3-dioxygenase inhibitors.
von: Röhrig, U, et al.
Veröffentlicht: (2010)

The role of placental tryptophan catabolism
von: Peter eSedlmayr, et al.
Veröffentlicht: (2014-05-01)

Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1
von: Fan Liang, et al.
Veröffentlicht: (2022-09-01)

Indoleamine 2,3‐dioxygenase gene expression and kynurenine to tryptophan ratio correlation with nasopharyngeal carcinoma progression and survival
von: Sameh Souissi, et al.
Veröffentlicht: (2022-09-01)

A Multifaceted Role of Tryptophan Metabolism and Indoleamine 2,3-Dioxygenase Activity in Aspergillus fumigatus–Host Interactions
von: Tsokyi Choera, et al.
Veröffentlicht: (2018-01-01)

Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort
von: Cryan John F, et al.
Veröffentlicht: (2009-01-01)

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
von: Aleksandar Acovic, et al.
Veröffentlicht: (2018-12-01)

Neopterin suppresses the activity of tryptophan-degrading enzyme indoleamine 2,3-dioxygenase in human peripheral blood mononuclear cells
von: Schroecksnadel Sebastian, et al.
Veröffentlicht: (2013-12-01)

Indoleamine-2,3-Dioxygenase Mediates Emotional Deficits by the Kynurenine/Tryptophan Pathway in the Ethanol Addiction/Withdrawal Mouse Model
von: Xi Jiang, et al.
Veröffentlicht: (2020-02-01)

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
von: Andrew L. Mellor, et al.
Veröffentlicht: (2017-10-01)

Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.
von: Orabona, C, et al.
Veröffentlicht: (2018)

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.
von: Larrea, E, et al.
Veröffentlicht: (2007)

Remarkable Role of Indoleamine 2,3-Dioxygenase and Tryptophan Metabolites in Infectious Diseases: Potential Role in Macrophage-Mediated Inflammatory Diseases
von: Yuki Murakami, et al.
Veröffentlicht: (2013-01-01)

The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
von: Christiane A Opitz, et al.
Veröffentlicht: (2011-01-01)

The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
von: Chiara Suvieri, et al.
Veröffentlicht: (2024-11-01)

Research progress of indoleamine 2,3-dioxygenase 1 in gastric cancer
von: Pei Xiaxia, et al.
Veröffentlicht: (2023-03-01)

Local Inhibition of Indoleamine 2,3-Dioxygenase Mitigates Renal Fibrosis
von: Camilla Grønkjær Jensen, et al.
Veröffentlicht: (2021-07-01)

Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
von: Asim Farooq, et al.
Veröffentlicht: (2022-09-01)

Comprehensive behavioral analysis of indoleamine 2,3‐dioxygenase knockout mice
von: Nao Hirata, et al.
Veröffentlicht: (2018-09-01)

The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
von: Yuhei Shibata, et al.
Veröffentlicht: (2016-01-01)

The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
von: Ding Ya, et al.
Veröffentlicht: (2009-08-01)

Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer
von: Tao Zhang, et al.
Veröffentlicht: (2017-01-01)

The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
von: Lilla Hornyák, et al.
Veröffentlicht: (2018-01-01)